ABCSG 62 / CAMBRIA-2: FIRST PATIENT IN at the University Clinic for Gynecology Innsbruck


Just two weeks ago, the Pyhrn-Eisenwurzen Clinic Steyr was the first center in Austria to be activated for the ABCSG 62 / CAMBRIA-2 trial. Now, on May 3rd, the Clinical Department of Gynecology and Obstetrics at the University Clinic for Gynecology in Innsbruck was able to enroll the first patient (FPI) within the COOP network, making Austria the first of 9 countries in the ABCSG network to randomize a patient in ABCSG 62 / CAMBRIA-2.

The ABCSG cordially congratulates PI Dr. Daniel Egle and his team!

The planned sample size of the ABCSG 62 / CAMBRIA-2 study worldwide is 5,500 participants, in Austria 144 patients are planned at 16 centers.

Share on